Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease-Reference-Cited by-同舟云学术

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease

Published:2014-03-11 Issue:4 Volume:29 Page:454-462
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Berg Daniela¹,Postuma Ronald B.²,Bloem Bastiaan³,Chan Piu⁴,Dubois Bruno⁵,Gasser Thomas¹,Goetz Christopher G.⁶,Halliday Glenda M.⁷,Hardy John⁸,Lang Anthony E.⁹,Litvan Irene¹⁰,Marek Kenneth¹¹,Obeso José¹²,Oertel Wolfgang¹³,Olanow C. Warren¹⁴,Poewe Werner¹⁵,Stern Matthew¹⁶,Deuschl Günther¹⁷

Affiliation:

1. Department of Neurodegeneration; Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases; Tuebingen Germany

2. Department of Neurology; Montreal General Hospital; Montreal Quebec Canada

3. Department of Neurology; Radboud University Nijmegen Medical Center; Nijmegen the Netherlands

4. Xuanwu Hospital of Capital Medical University; Beijing People's Republic of China

5. Department of neurology; Salpêtrière Hospital, APHP, University Paris 6; UPMC, Paris France

6. Rush University Medical Center; Chicago Illinois USA

7. Neuroscience Research; Randwick; Australia and the University of New South Wales; Sydney Australia

8. Department of Molecular Neuroscience; UCL Institute of Neurology; London UK

9. Edmond J Safra Program in Parkinson's Disease; Division of Neurology, Toronto Western Hospital and the University of Toronto; Toronto Canada

10. Department of Neurosciences; University of California San Diego; La Jolla California USA

11. Institute for Neurodegenerative Disorders; New Haven Connecticut USA

12. University of Navarra-FIMA; Pamplona Spain

13. Department of Neurology; Philipps University of Marburg; Marburg Germany

14. Department of Neurology; The Mount Sinai Hospital; New York New York USA

15. Department of Neurology; Innsbruck Medical University; Innsbruck Austria

16. Penn Neurological Institute; Philadelphia Pennsylvania USA

17. Department of Neurology; Christian-Albrechts University; Kiel Germany

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.25844/fullpdf

Reference63 articles.

1. Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation;Wider;Neurodegener Dis,2010

2. The neuropathology of genetic Parkinson's disease;Poulopoulos;Mov Disord,2012

3. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders;Beach;Acta Neuropathol,2010

4. Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance;Parkkinen;Acta Neuropathol,2008

5. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease;Dickson;Acta Neuropathol,2008

Cited by 382 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological Heterogeneity of Lewy Body Diseases: The Profound Influence of Comorbid Alzheimer’s Disease;2024-09-04

2. Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort;CNS Neuroscience & Therapeutics;2024-08

3. Cholesterol Metabolism in Neurodegenerative Diseases;Antioxidants & Redox Signaling;2024-07-11

4. Replication and reliability of Parkinson's disease clinical subtypes;Parkinsonism & Related Disorders;2024-07

5. Exploring the utility of process scores in elucidating the role of cognitive and affective factors that influence verbal fluency performance in Parkinson’s disease;Applied Neuropsychology: Adult;2024-06-03